Bohlin Garen G
SEC-identified person · CIK 1254705 Identifier-verified
Public-company roles (from insider filings)
| Company | Capacity as filed | Filings |
|---|---|---|
| Karyopharm Therapeutics Inc. KPTI | Director | filed 2013 - 2026 |
| Collegium Pharmaceutical, INC COLL | Director | filed 2015 - 2026 |
| Tetraphase Pharmaceuticals INC TTPH | Director | filed 2013 - 2019 |
| Protara Therapeutics, Inc. TARA | Director | filed 2014 - 2018 |
| Acusphere INC ACUS | Director | filed 2006 - 2009 |
| Targanta Therapeutics Corp. TARG | Director | filed 2007 - 2008 |
| Sirtris Pharmaceuticals, Inc. SIRT | COO and Assistant Secretary | filed 2007 - 2008 |
| Praecis Pharmaceuticals INC PRCS | Director | filed 2007 - 2007 |
All roles under one Commission-assigned identifier - the same person by the SEC's own record, not by name matching. From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.